Rare Endocrine Exchange

In this episode, endocrinologist Margarita Ochoa-Maya, MD, speaks with endocrinologist Katherine Arakay, MD, of the University of California, Los Angeles (UCLA), about clinical trials for rare endocrine disorders. The conversation examines clinical trials from three perspectives: patients, clinical researchers, and sponsors.

For people living with rare endocrine disorders, getting an accurate diagnosis can be a long and frustrating journey. Symptoms may be subtle, overlap with more common conditions, or involve multiple organ systems, making it difficult for healthcare providers to recognize the underlying disorder.

In this episode of the Rare Endocrine Exchange, endocrinologists Dr. Margarita Ochoa-Maya and Dr. Jim Radke discuss why diagnostic delays occur and what can be done to help patients reach the right diagnosis sooner.

The conversation explores several important questions:

• Why are rare endocrine disorders so difficult to diagnose? Symptoms may not immediately point to a specific rare condition, and patients may see multiple providers before the pieces come together.
• What is the impact of a delayed diagnosis? Waiting months or years for answers can affect a patient's health, quality of life, and confidence in the healthcare system.
• How can clinicians bridge the diagnostic gap? Recognizing patterns, considering rare diseases when symptoms don't fit, and knowing when to seek additional expertise can help move the diagnostic process forward.
• What should providers do when they don't know what to do next? With thousands of rare diseases, no physician can know them all. Knowing when and where to seek guidance is an important part of caring for patients with complex conditions.
• How can specialists work together more effectively? Rare endocrine disorders often require input from multiple specialties. Better communication and collaboration can help connect the dots and prevent patients from falling through the cracks.

The discussion also looks ahead at how patients, providers, and the healthcare system can work together to reduce diagnostic delays and improve care for people living with rare endocrine disease.
Watch the full conversation to hear Dr. Ochoa-Maya and Dr. Radke share their perspectives on improving the path to diagnosis and care.

Rare endocrine disorders can be difficult to recognize, challenging to diagnose, and even harder for patients to navigate. For many patients, the journey to an accurate diagnosis can take years.

Rare Endocrine Exchange, a new podcast from CheckRare, aims to change that.
Hosted by clinical endocrinologist Margarita Ochoa-Maya, MD, the series brings together physicians, researchers, patients, advocates, and other leaders across the rare endocrine community to explore the science, challenges, and real-world experiences behind these disorders.

In this inaugural episode, Dr. Ochoa-Maya introduces the Rare Endocrine Exchange and discusses why greater awareness and collaboration are needed across rare endocrine diseases. Future episodes will explore some of the most important issues facing the community, including:

• Why are rare endocrine disorders diagnosed so slowly?
• Can AI help (or hurt) rare endocrine care?
• What do new guidelines mean for patients with rare endocrine diseases?
• The latest research and clinical advances
• Patient and caregiver experiences
• Advocacy and access to care
• Emerging treatments and clinical trials

The goal is simple: to create a place where the rare endocrine community can learn from one another.

Whether the conversation is with a leading researcher, a practicing clinician, a patient, or an advocate working to change the system, Dr. Ochoa-Maya will explore the issues that matter most to the people living with and caring for rare endocrine disorders.

This is the Rare Endocrine Exchange.